AT235237T

The use of sertraline to treat post myocardial infarction patients

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

23 members in 15 offices

This recordMember, by publication datePriority claim5 more offices are in the list below

Priority claims4

Priority claims
DocumentOfficeKindDate
143795United States of AmericaP
143795United States of AmericaP
1437
US19950001437P

Members23

Family members, oldest first
DocumentOfficeKind
IL118833A0IsraelA0
IL118833D0IsraelD0
CA2181225A1CanadaA1
AU6053496AAustraliaA
JPH0930959AJapanA
KR970005283ARepublic of KoreaA
EP0768083A2European Patent Office (EPO)A2
CN1147937AChinaA
ZA966027BSouth AfricaB
CA2181225CCanadaC
EP0768083A3European Patent Office (EPO)A3
AU721967B2AustraliaB2
IL118833AIsraelA
NZ299006ANew ZealandA
EP0768083B1European Patent Office (EPO)B1
AT235237TThis recordAustriaT
ATE235237T1AustriaT1
DE69626916D1GermanyD1
DK0768083T3DenmarkT3
PT768083EPortugalE
ES2192217T3SpainT3
DE69626916T2GermanyT2
MY117638AMalaysiaA